Maryles Joel Michael's Form 4 filing
Chemomab Therapeutics Ltd. (CMMB) · filed Mar 21, 2022
- Accession no.
- 0001178913-22-001181
- Filed
- Mar 21, 2022
- Trade date
- Apr 19, 2021-Mar 18, 2022
- Filing delay
- 336 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market purchases total $4.34K. It was filed 336 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maryles Joel MichaelCIK 0001850990 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2022 | American Depositary Shares | PPurchaseAcquired | +500 | $4.32 | +$2,160 | 500 | Direct | |
| Mar 18, 2022 | American Depositary Shares | PPurchaseAcquired | +500 | $4.36 | +$2,180 | 1,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2022 | American Depositary Shares | AGrant or awardAcquired | +6,820 | $0.00 | $0 | 6,820 | Direct | Duplicate filing |
| Apr 19, 2021 | American Depositary Shares | AGrant or awardAcquired | +11,884 | $0.00 | $0 | 11,884 | Direct | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.